Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2005 | 12-2004 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 4,780 | 352 |
| Marketable Securities | 52 | 33 |
| Receivables | 21 | N/A |
| TOTAL | $4,907 | $462 |
| Non-Current Assets | ||
| PPE Net | 84 | 2,010 |
| Intangibles | 1,833 | N/A |
| Other Non-Current Assets | 3 | 0 |
| TOTAL | $1,921 | $2,010 |
| Total Assets | $6,827 | $2,473 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 165 | 137 |
| Accounts payable and accrued liabilities | 550 | 155 |
| TOTAL | $714 | $292 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 1,561 | 1,601 |
| TOTAL | $1,569 | $1,603 |
| Total Liabilities | $2,283 | $1,894 |
| Shareholders' Equity | ||
| Retained earnings | -3,634 | -790 |
| Other shareholders' equity | 0 | 129 |
| TOTAL | $4,544 | $578 |
| Total Liabilities And Equity | $6,827 | $2,473 |